Shandong Weigao Orthopaedic Device Co. Ltd. A (688161) — Cash Flow Reinvestment Rate

Latest as of December 2025: 1.52x

Shandong Weigao Orthopaedic Device Co. Ltd. A (688161) has a Cash Flow Reinvestment Rate of 1.52x as of December 2025, reinvesting CN¥632.83 Million (capex CN¥27.09 Million plus investments CN¥-605.74 Million) from operating cash flow of CN¥415.42 Million. Check 688161 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

1.52x
(Capex + Investments) / Operating CF

Total Reinvested

CN¥632.83 Million
Capex + Investments

Operating Cash Flow

CN¥415.42 Million
CNY

Capital Expenditures

CN¥27.09 Million
CNY

Shandong Weigao Orthopaedic Device Co. Ltd. A Cash Flow Reinvestment Rate (2019–2025)

Historical reinvestment intensity for Shandong Weigao Orthopaedic Device Co. Ltd. A across 7 annual periods. Explore 688161 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for Shandong Weigao Orthopaedic Device Co. Ltd. A (2019–2025)

Year-by-year capital reinvestment analysis for Shandong Weigao Orthopaedic Device Co. Ltd. A. For live market cap and broader valuation context, see Shandong Weigao Orthopaedic Device Co. L stock valuation.

Year Reinvestment Rate Total Reinvested (CNY) Operating CF Capex YoY Change
2025 1.52x CN¥632.83 Million CN¥415.42 Million CN¥27.09 Million ▲ +115.1%
2024 0.71x CN¥194.19 Million CN¥274.19 Million CN¥24.34 Million ▼ -32.1%
2023 1.04x CN¥124.55 Million CN¥119.44 Million CN¥42.98 Million ▲ +116.3%
2022 0.48x CN¥245.22 Million CN¥508.56 Million CN¥115.76 Million ▼ -70.8%
2021 1.65x CN¥1.30 Billion CN¥788.25 Million CN¥112.41 Million ▲ +1007.6%
2020 0.15x CN¥95.94 Million CN¥644.12 Million CN¥49.59 Million ▲ +14.6%
2019 0.13x CN¥69.42 Million CN¥534.15 Million CN¥28.94 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow